Better Capital PCC 2012 (Ordinary Share) BC12

Private Equity

Register or Sign in to receive email alerts for items in your favourites whenever we write about them

Add to Virtual Portfolio | Print page

Estimated NAV (p)

107.00

Share Price (p)

83.00

Total Returns on £1000 over 

Fund / Benchmark Total returns(%)
Better Capital PCC 2012 (Ordinary Share) Price -23.01%
Better Capital PCC 2012 (Ordinary Share) NAV 2.02%
LPX United Kingdom 8.62%
Total Returns on £1000

Discount / Premium Movement

Discount / Premium Movement

Shares

Share Type Yesterday's
Closing Price
Discount / Premium Diluted NAV Gearing Dividend
Est Last
Ordinary Share 83.5p -21.7% 107.00p 108.00p
31 Mar
100%

Discrete performance % over

Fund / BenchmarkQ1Q2Q3Q4
Better Capital PCC 2012 (Ordinary Share) Price-23.01
Better Capital PCC 2012 (Ordinary Share) NAV2.02
LPX United Kingdom8.62

Discrete performance over

Discrete Performance

Top 10 Holdings

Everest 42.06%
Jaeger 31.46%
City Link 26.49%

Sectors weighting

Net Current Assets 59.80%
Unlisted Equities 40.20%
  • Investment trust info:

  • Sector Private Equity
  • Launch Date 13 Jan 2012
  • Base Currency GBX
  • Domicile Guernsey
  • Share Price (p) 83.00
  • Share Type Ordinary Share
  • TIDM BC12
  • ISIN GG00B4N1RV71
  • Shares Issued (M) 347
  • Market Capital (£M) 289.41
  • Gross Assets (£M) 369.55
  • Net Assets (£M) 369.55
  • TER (%) 0.24
  • Last AGM 31 Jul 2014
  • Next AGM 31 Jul 2015
  • Last Annual Report Date 04 Aug 2014
  • Next due Report Date  
  • Next due Report Type I/R
  • Objective:

  • To invest in a portfolio of businesses (primarily in the UK or Ireland) which have significant operating issues and may have associated financial distress, with a view to generating attractive total returns.
  • Management Group(s):

  • Heritage International FM
  • Managed by:

  • Team Managed Start: 13 Jan 2012
  • Team Managed Start: 13 Jan 2012
  • Team Managed Start: 13 Jan 2012
  • Management Contract & Fees:

    After the Conversion to the PCC, the Administrator receives an annual fee, subject to an overall cap of GBP 250,000 per annum as a whole, of: 1) an ad valorem fee of 0.1% of the NA per annum of the first GBP 100m and 0.05% thereafter of each of 2009 cell and 2012 cell subject to a minimum fee of GBP 75,000 per annum per Cell; and 2) a fee of GBP 5,000 per annum in respect of the Core.